Gen-Probe and bioMerieux share know-how
This article was originally published in Clinica
Executive Summary
San Diego nucleic acid diagnostics firm Gen-Probe and French group bioMerieux have signed a series of agreements that will enable them to use each other's know-how to develop new tests. At the same time, they have dissolved an earlier licence deal.